Grupo para la caracterización molecular de las neoplasias hematológicas
German Cancer Research Center
Heidelberg, AlemaniaPublicaciones en colaboración con investigadores/as de German Cancer Research Center (25)
2023
-
A pleiotropic variant in DNAJB4 is associated with multiple myeloma risk
International Journal of Cancer, Vol. 152, Núm. 2, pp. 239-248
-
Characteristics and outcome of patients with acute myeloid leukemia and trisomy 4
Haematologica, Vol. 108, Núm. 1, pp. 34-41
-
Identification of novel genetic loci for risk of multiple myeloma by functional annotation
Leukemia
-
Polymorphisms within Autophagy-Related Genes as Susceptibility Biomarkers for Multiple Myeloma: A Meta-Analysis of Three Large Cohorts and Functional Characterization
International Journal of Molecular Sciences, Vol. 24, Núm. 10
2022
-
Does a Multiple Myeloma Polygenic Risk Score Predict Overall Survival of Patients with Myeloma?
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, Vol. 31, Núm. 9, pp. 1863-1866
2021
-
Common gene variants within 3′-untranslated regions as modulators of multiple myeloma risk and survival
International Journal of Cancer, Vol. 148, Núm. 8, pp. 1887-1894
-
Do myeloproliferative neoplasms and multiple myeloma share the same genetic susceptibility loci?
International Journal of Cancer, Vol. 148, Núm. 7, pp. 1616-1624
-
Expression quantitative trait loci of genes predicting outcome are associated with survival of multiple myeloma patients
International Journal of Cancer, Vol. 149, Núm. 2, pp. 327-336
-
Genetically determined telomere length and multiple myeloma risk and outcome
Blood Cancer Journal, Vol. 11, Núm. 4
-
Publisher Correction: Outcome of older (≥70 years) APL patients frontline treated with or without arsenic trioxide—an International Collaborative Study (Leukemia, (2020), 34, 9, (2333-2341), 10.1038/s41375-020-0758-4)
Leukemia
2020
2019
-
Exome sequencing identifies germline variants in DIS3 in familial multiple myeloma
Leukemia
-
Genetic polymorphisms in genes of class switch recombination and multiple myeloma risk and survival: an IMMEnSE study
Leukemia and Lymphoma, Vol. 60, Núm. 7, pp. 1803-1811
2018
-
Inherited variation in the xenobiotic transporter pathway and survival of multiple myeloma patients
British Journal of Haematology, Vol. 183, Núm. 3, pp. 375-384
2017
-
Identification of miRSNPs associated with the risk of multiple myeloma
International Journal of Cancer, Vol. 140, Núm. 3, pp. 526-534
-
Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: A multicenter IMWG study
Leukemia, Vol. 31, Núm. 11, pp. 2443-2448
-
Second primary malignancies in multiple myeloma: An overview and IMWG consensus
Annals of Oncology, Vol. 28, Núm. 2, pp. 228-245
2016
-
A common variant within the HNF1B gene is associated with overall survival of multiple myeloma patients: Results from the IMMEnSE consortium and meta-analysis
Oncotarget, Vol. 7, Núm. 37, pp. 59029-59048
2015
-
Cytogenetics and long-term survival of patients with refractory or relapsed and refractory multiple myeloma treated with pomalidomide and low-dose dexamethasone
Haematologica, Vol. 100, Núm. 10, pp. 1327-1333